Erin M. Burns, MS, PhD
Cancer Prevention and Control Trainee
Primary Mentor: Nabiha Yusuf, PhD
Secondary Mentor: Craig A. Elmets, MD
Originally from Greenwood, IN, Dr. Burns received her B.A in Biology with minors in Chemistry and Spanish in 2007 from Ball State University in Muncie, IN. She remained at Ball State University until 2009, completing a Biotechnology Certification Program and an M.S. in Biology, where her thesis research focused on immune responses of mice infected with S. aureus in the laboratory of Dr. Heather A. Bruns. After enjoying four years as a Buckeye, Dr. Burns received her Ph.D. in 2013 from The Ohio State University, where she performed her dissertation research in the laboratory of Dr. Tatiana M. Oberyszyn, studying the role of sex-based differences in the prevention of non-melanoma skin cancer. She received the Outstanding Graduate Student in Laboratory Sciences Award in 2009 and the Graduate Student of the Year Award for the Department of Pathology in 2013. Dr. Burns’ research interests include skin cancer, topical and nutritional interventions, immunology, and epidemiology. She can often be found singing and dancing at home, in the car, or even in the lab. Outside of her research, Erin especially enjoys football and painting.
Dissertation Title: Men and Women Are Not Just From Different Planets: The Role of Sex-Based Differences in the Prevention of Non-Melanoma Skin Cancer
Selected Courses/Conferences Attended
- 2013 International Investigative Dermatology Meeting (May 2013; Edinburgh, Scotland)
Poster: Size is not a reliable predictor of tumor grade in a murine UVB-induced carcinogenesis model
- 10th International Skin Carcinogenesis Conference (June 2012; Columbus, OH)
Poster: Diclofenac decreases tumor burden in male and female mice in two models of UVB-induced squamous cell carcinoma
- 2012 Society for Investigative Dermatology Annual Meeting (May 2012; Raleigh, NC)
Oral Presentation: Diclofenac decreases tumor burden in male and female mice in two models of UVB-induced squamous cell carcinoma
- 2011 Society for Investigative Dermatology Annual Meeting (May 2011; Phoenix, AZ)
Oral Presentation: Sex differences in UVB-induced cutaneous tumor development in Skh-1 mice following topical antioxidant/anti-inflammatory treatment
- Autumn Immunology Conference (November 2008; Chicago, IL)
Oral Presentation: Immune responses of S. aureus-infected mice pre-treated with simvastatin
- Burns, EM, KL Tober, JA Riggenbach, DF Kusewitt, GS Young, and TM Oberyszyn. (2013) Differential effects of topical vitamin E and C E Ferulic treatmentsultraviolet light B-induced cutaneous tumor development in Skh-1 mice. PLOS ONE 8(5):e63809.
- Burns, EM, LK Smelser, JE Then, TE Stankiewicz, M Kushdilian, SA McDowell, and HA Bruns. (2013) Short term statin treatment improves survival and differentially regulates macrophage-mediated responses to Staphylococcus aureus. Curr Pharmeceut Biotech 14(2): 233-241.
- Burns, EM, KL Tober, JA Riggenbach, JS Schick, KN Lamping, GS Young, DF Kusewitt, and TM Oberyszyn. (2013) Preventative topical diclofenac treatment differentially decreases tumor burden in male and female Skh-1 mice in a model of UVB-induced cutaneous squamous cell carcinoma. Carcinogenesis 34(2): 370-377.
- Sullivan, NJ, KL Tober, EM Burns, JS Schick, JA Riggenbach, TA Mace, MA Bill, GS Young, TM Oberyszyn, and GB Lesinski. (2012) UV light B-mediated inhibition of skin catalase activity promotes Gr-1(+)Cd11b(+) myeloid cell expansion. J Invest Dermatol 132 (3 Pt 1): 695-702.